biologic

Thyrogen

thyrotropin alfa

Loss of exclusivityNovember 2010projected — 12-year biologic exclusivity estimate
CompanyGenzyme Corporation

Drug detail

Brand nameThyrogen
Active ingredientthyrotropin alfa
Strength0.9MG
Dosage formFor Injection
RouteIntramuscular
ModalityBiologic
FDA approvalNovember 1998
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Thyrogen patent cliff — loss of exclusivity November 2010 | CliffBio